These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9529666)

  • 1. Psychophysiological aspects of amphetamine-methamphetamine abuse.
    Murray JB
    J Psychol; 1998 Mar; 132(2):227-37. PubMed ID: 9529666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 5. DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction.
    Baig AM
    ACS Chem Neurosci; 2018 Oct; 9(10):2299-2303. PubMed ID: 29671582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers.
    Gustavsen I; Mørland J; Bramness JG
    Accid Anal Prev; 2006 May; 38(3):490-5. PubMed ID: 16343411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance misuse and early psychosis.
    Tucker P
    Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of methamphetamine use disorder treated with the antibiotic drug minocycline.
    Tanibuchi Y; Shimagami M; Fukami G; Sekine Y; Iyo M; Hashimoto K
    Gen Hosp Psychiatry; 2010; 32(5):559.e1-3. PubMed ID: 20851278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enacting multiple methamphetamines: the ontological politics of public discourse and consumer accounts of a drug and its effects.
    Dwyer R; Moore D
    Int J Drug Policy; 2013 May; 24(3):203-11. PubMed ID: 23540297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial.
    Thompson RG; Oliveto A; Thostenson JD; Wilson MP; McGaugh J; Mancino MJ
    J Psychopharmacol; 2021 Nov; 35(11):1420-1430. PubMed ID: 34697965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
    PROUT CT
    N Y State J Med; 1964 May; 64():1186-92. PubMed ID: 14144137
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features of nicotine dependence compared with those of alcohol, methamphetamine, and inhalant dependence.
    Miyata H; Kono J; Ushijima S; Yanagita T; Miyasato K; Fukui K
    Ann N Y Acad Sci; 2004 Oct; 1025():481-8. PubMed ID: 15542752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
    Chiang YC; Chen JC
    J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
    Harro J
    Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.
    Tolliver BK; McRae-Clark AL; Saladin M; Price KL; Simpson AN; DeSantis SM; Baker NL; Brady KT
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):106-13. PubMed ID: 20337507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine, the brain, HIV, and mental health.
    Jones K
    Focus; 2005 Jul; 20(6):1-5. PubMed ID: 16110566
    [No Abstract]   [Full Text] [Related]  

  • 19. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
    Rawls SM; Cavallo F; Capasso A; Ding Z; Raffa RB
    Eur J Pharmacol; 2008 Apr; 584(2-3):278-84. PubMed ID: 18342307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine attenuates relapse to methamphetamine-seeking behavior (craving) in rats.
    Hiranita T; Anggadiredja K; Fujisaki C; Watanabe S; Yamamoto T
    Ann N Y Acad Sci; 2004 Oct; 1025():504-7. PubMed ID: 15542755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.